A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Wanbo Tai; Xiujuan Zhang; Aleksandra Drelich; Juan Shi; Jason C. Hsu; Larry Luchsinger; Christopher D. Hillyer; Chien Te K. Tseng; Shibo Jiang; Lanying Du

doi:10.1038/s41422-020-0387-5

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Wanbo Tai, Xiujuan Zhang, Aleksandra Drelich, Juan Shi, Jason C. Hsu, Larry Luchsinger, Christopher D. Hillyer, Chien Te K. Tseng, Shibo Jiang, Lanying Du

Microbiology And Immunology

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	932-935
Number of pages	4
Journal	Cell Research
Volume	30
Issue number	10
DOIs	https://doi.org/10.1038/s41422-020-0387-5
State	Published - Oct 1 2020

ASJC Scopus subject areas

Molecular Biology
Cell Biology

Access to Document

10.1038/s41422-020-0387-5

Cite this

@article{115804ca22d14911924ac0b10ce3c15b,

title = "A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2",

author = "Wanbo Tai and Xiujuan Zhang and Aleksandra Drelich and Juan Shi and Hsu, {Jason C.} and Larry Luchsinger and Hillyer, {Christopher D.} and Tseng, {Chien Te K.} and Shibo Jiang and Lanying Du",

note = "Funding Information: This work was supported by National Institutes of Health (NIH) grants (R01AI137472 and R01AI139092) and New York Blood Center funds (VIM-NYB616 and VIM-NYB673).",

year = "2020",

month = oct,

day = "1",

doi = "10.1038/s41422-020-0387-5",

language = "English (US)",

volume = "30",

pages = "932--935",

journal = "Cell Research",

issn = "1001-0602",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

AU - Tai, Wanbo

AU - Zhang, Xiujuan

AU - Drelich, Aleksandra

AU - Shi, Juan

AU - Hsu, Jason C.

AU - Luchsinger, Larry

AU - Hillyer, Christopher D.

AU - Tseng, Chien Te K.

AU - Jiang, Shibo

AU - Du, Lanying

N1 - Funding Information: This work was supported by National Institutes of Health (NIH) grants (R01AI137472 and R01AI139092) and New York Blood Center funds (VIM-NYB616 and VIM-NYB673).

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85089029858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089029858&partnerID=8YFLogxK

U2 - 10.1038/s41422-020-0387-5

DO - 10.1038/s41422-020-0387-5

M3 - Letter

C2 - 32759966

AN - SCOPUS:85089029858

SN - 1001-0602

VL - 30

SP - 932

EP - 935

JO - Cell Research

JF - Cell Research

IS - 10

ER -

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this